X4 Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. SPCX
2. CRNX
3. VRTX
4. WMT
5. LMT
6. RXST
7. SPY
8. SPGI
9. RIVN
10. CMPS

Go back to X4 Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update

X4 Pharmaceuticals (XFOR) Misses Q3 EPS by 11c

November 5, 2020 8:25 AM EST

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q3 EPS of ($0.87), $0.11 worse than the analyst estimate of ($0.76).

The third quarter was highlighted by the publication of our positive Phase 2 safety and efficacy data for mavorixafor in WHIM syndrome in the prestigious journal, Blood, which, we believe,... More